Meeting
2024 ASCO Annual Meeting
Evaluation of a novel extracellular vesicle (EV) based ovarian cancer (OC) screening test in asymptomatic postmenopausal women.
Authors
Brendan Manning
Mercy BioAnalytics, Inc., Waltham, MA
Brendan Manning , Sanchari Banerjee , Laura T Bortolin , Emily S. Winn-Deen , Bilal Hamzeh , Brittany Grimes , Timothy Santos-Heiman , Delaney M. Byrne , Troy B Hawkins , MacKenzie Sadie King , Daniel P. Salem , Michael Smith , Sophia Apostolidou , Aleksandra Gentry-Maharaj , Christine D. Berg , Steven Skates , David Ransohoff , Toumy Guettouche , Dawn R Mattoon , Usha Menon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 5553)
DOI
10.1200/JCO.2024.42.16_suppl.5553
Abstract #
5553
Poster Bd #
424
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Extracellular vesicle-based biomarker assay for the detection of early-stage ovarian cancer.
First Author: Laura Bortolin
Poster
2015 ASCO Annual Meeting
Role of HE4, CA125, and ultrasound in risk assessment in pelvic mass patients: Results from a prospective, multicentric study.
First Author: Elena Ioana Braicu
Poster
2023 ASCO Gastrointestinal Cancers Symposium
CA125 kinetics as a potential biomarker for ascites progression during taxane plus ramucirumab therapy in patients with advanced gastric cancer.
First Author: Akira Ueda
Poster
2017 ASCO Annual Meeting
Circulating free DNA and circulating tumor cells as new serum biomarkers in advanced ovarian cancer.
First Author: Jeronimo Martinez garcia